drbob66

Silver Prices Are About to Fall

"based on charts I've examined, the way I see things, silver prices could temporarily fall to $11 per troy, again, or even lower, before March 2010. "

Well, according to MY chart analysis, silver may pull back to around $14.50 (NOT $11)...and then continue upward to $20. Sure, I could trade around that and attempt to avoid a maybe 10-15% decline in paper gains...but instead I think I'll take the opportunity to ADD to my silver position on weakness.

"Prognostications as to exact prices, of course, are seldom accurate."

At least you got that part right. Still, I say silver will hit $20 before it sees $11.

ETrade: Not for the Faint Hearted

Huge gap at $8.02 from Nov 2007. It needs to be filled sometime (could take a while, though). A (very) patient investor could be looking at a five bagger from today's levels.

Rolling Stone's Taibbi on Naked Short Sales: Close but No Cigar

Interesting link...


On Oct 22 11:42 PM John O wrote:

> I was an options market maker on the PSE for 5 years and the CBOE
> for 5 years and traded options and stocks short and long in about
> every conceivable situation. I am intimately familiar with the Bear
> Stearns take down.
> I will say that the author here and Taibbi and others who believe
> that naked short sellers caused the Bear Stearns crash do not have
> a clue to what has happened or they are deliberately misdirecting
> the blame away from people like Dimon, Bernanke, Cox, Cramer, and
> many others who stole billions from illegal insider trading.
>
> Just ask Cui Bono? and the answer becomes the illegal inside traders
> and J.P. Morgan.
>
> See the real explanation of Bear Stearns below:
>
> www.optionsforemployee...

Why Apple Is Worth $80

LOL, I love this kind of article. It reminds me of a guy that I used to follow on the internet...he has a site called "trading with TK" (www.tradingwithtk.com/). You can check his "current positions" right on that site, and you can see that he shorted AAPL on March 5 at $90. He used to update his trades daily...until March 29, when he posted his last comment: "On a few weeks vacation."

I hope the author doesn't expect to hold his short AAPL position until it gets to $80...if so, I expect he'll be going on "a few weeks vacation" soon enough.

The Nine Best Natural Gas, Oil Pipelines for Income and Capital Gains

Buy AHD now, and hold it for a while..it will be $20.90 within 3 years (current price $3.94).

And don't forget...you heard it here first.

You're welcome.

Why I'm Long Mortgage REIT Chimera

NLY just boosted their quarterly dividend to $.69 last night (now yielding 14%)...this stock has been a monster for me this year, so I say THANKS to Mike Farrell and all the dedicated employees at Annaly for making me mucho dinero! Keep up the good work!

Sorry, Patrick, RWT looks nice, but they're only paying 6% divy at the moment. I'd buy ANH or CMO before RWT...but I have enough money in REITs right now, so I'm holding my NLY and some ANH bought earlier this year.


On Sep 01 01:53 PM Patrick Harden wrote:

> I'm not entirely sure that I buy into Annaly's divide and conquer
> methodology on the distressed debt orgy. First of all, they were
> way too early in effectively calling the non-agency backed RMBS bottom
> with the Chimera IPO. On the heels of that disaster, Annaly now
> has another spinoff for the commercial side of the house in CreXus
> (how do you even pronounce that?).
>
> I'm not convinced that the Annaly machine has enough experience outside
> of the agency arena to run either REIT, frankly. Chimera's only
> defensive strategy during the 2008 crisis was to launch one dilutive
> secondary after another -- perhaps just throwing good money after
> bad in an attempt to bury bad paper deep in the portfolio.
>
> I think investors stand a better shot with Redwood Trust (seekingalpha.com/symbo...),
> which has much more relevant experience in non-agency MBS than Chimera
> & crew. Even one of the newly launched vulture REITs will have
> a cleaner balance sheet and less share dilution.

Extreme FDA Trades: 30 Stocks Under 5 Bucks

intranasal ketamine? really? Thanks for this info, this is interesting. I had no idea anyone was developing ketamine for this purpose.

For anyone interested, check out this link about DM Turner, a "psychonautic researcher" who drowned in his bathtub while tripping on "Special K." He was hooked on the stuff for many years.

www.erowid.org/culture...


On Aug 10 01:06 PM Mike Havrilla wrote:

> Check out this good, recent update article for JAV:
> seekingalpha.com/artic...
>
>
> JAV also mentioned above in my extreme trade article for pending
> Ereska Phase 3 results:
>
> Ereska is a non-opiate pain drug being developed by (1) Javelin Pharma
> (AMEX:seekingalpha.com/symbo...)($1.90) for the acute treatment
> of moderate to severe pain in military, trauma, post-operative, and
> emergency room settings with the potential for treating breakthrough
> pain from cancer as well. The drug is delivered by a disposable manual
> pump with a rapid onset and duration of pain relief of about two
> hours without opiate side effects such as respiratory depression.
> JAV expects to release the primary endpoint data from the Ereska
> (intranasal ketamine) Phase 3 pivotal trial in mid-2009, which consists
> of 220 adult patients to evaluate the safety and effectiveness of
> the drug in the treatment of acute pain (arising from surgery, trauma,
> or injury).

Hedging Your Way to Healthy Dividends: Part 1

Good article. Thanks.

This is Not a Bull Market: Stocks Are Not Up, and They’re Headed Even Lower

"I like the name of the post but the post doesn't explain why stock are headed lower, it doesn't even mention it. "

Interesting comment. Similar in tone to many here on SA. Could say a lot about the mindset of the general investing public (or maybe just about the mindset of people who make comments on sites like this). Why would a person "like" the idea of stocks going down? A short-seller...who stands to gain from a decline? Or, an investor...who wishes to buy a favorite stock at a lower price? Or...maybe just a guy who doesn't own stocks, and relishes the idea that those who do will suffer losses?

Either way...notwithstanding the concerns expressed by some financial pundits that currents levels of bullishness are evidence of the inevitability of further declines, I'm glad to see the bears are as pessimistic as ever here on SA. Makes me think this rally could still have legs.


On May 24 08:52 AM Steven Alexander Fortin wrote:

> I like the name of the post but the post doesn't explain why stock
> are headed lower, it doesn't even mention it.

Looking for the Next Dendreon? Consider Oncothyreon

ONTY down 23% today on a stock offering.
Ouch!

Where the Big Money Is Betting Big

Ha, I bought a little XOMA at 41 and 64 cents, and it's quite a volatile little stock. Seems to be a good trading vehicle, but the fundamental story is still unclear at this point. Could be improving, but then again, maybe not. Still, it's trading at $0.83 currently, so I'm up about 60% on this little speculative bet. Who knows, maybe someday they'll achieve the goal of consistent profitability. After all, they've been a public company for more than twenty years...how much longer could an investor have to wait, right?


On May 15 11:20 PM Northstar10000 wrote:

> Try
> XOMA it has been trading hugh volume. average volume about 1 million
> per day. today 41 million !

Navigating the Micro-Cap Biotech Minefield

Hmmm...does the author have any favorites? Or any opinion at all about these companies? And...I don't see any table. Where did it go? Am I too late reading this article?

Race to Develop Bioterrorism Vaccine

Here we go, folks....XOMA is trading at $1.39 in after-hours today. Good thing I picked up another 500 shares at 56 cents a few weeks ago. I think I'll ring the register on at least part of my position tomorrow.


On Apr 29 08:10 PM drbob66 wrote:

> XOMA is beginning to breakout from a long-term downtrend. It's up
> 38% in three days on above-average volume. My official buy signal
> will be a close above $1.03, but I started building a position at
> $0.41 last week.
>
> Watch this one, folks...

Race to Develop Bioterrorism Vaccine

XOMA is beginning to breakout from a long-term downtrend. It's up 38% in three days on above-average volume. My official buy signal will be a close above $1.03, but I started building a position at $0.41 last week.

Watch this one, folks...

In the Bargain Bin: American Oriental Bioengineering

Anybody else been watching the chart of AOB lately? I'm no expert at technical analysis, but it looks to me as if it's trying to break through an 11-month downtrend line. I bought some at $4.28 yesterday, and I may try to snag the other half tomorrow if the price action is good. The volume needs to pick up, at the very least. My guess is that $4.14 will be the make-or-break price for a continuation of the move higher in this stock. I suppose their Q1 earnings report on May 7 will dictate whether this stock is really a "bargain" at these prices.